Corporate News

Colorescience® Receives Patent for Formulation of Even Up® Clinical Pigment Perfector®

The Even Up® Clinical Pigment Perfector® is recognized by the US Patent and Trademark Office (USPTO) for its formulation of the LUMIRA™ complex

Carlsbad, CA (July 2018) – Colorescience® is pleased to announce that the US Patent and Trademark Office (USPTO) has granted a patent (US Patent No. 9,956,163) for the company’s innovative LUMIRA™ formulation, a clinically tested, highly effective complex that addresses the appearance of skin discoloration, found in the 3-in-1 treatment product, Even Up® Clinical Pigment Perfector®. 

The now patented formulation found in Even Up® Clinical Pigment Perfector® is an advanced treatment product that offers users three-in-one skincare benefits of SPF 50 all mineral protection, immediate color correction benefits and ingredients that address the pigmentation pathway in the long term.

“It is rewarding to see that the USPTO recognizes the innovation and exceptionality of Even Up Clinical Pigment Perfector much as our clinical partners and devoted patients have for several years,” noted Mary Fisher, CEO of Colorescience.

Recognized as an important part of managing hyperpigmentation by hundreds of dermatologists as well as tens of thousands of patients and consumers, the Even Up® Clinical Pigment Perfector® was used in a single-center clinical trial to assess efficacy and tolerability of a new multifunctional facial product when used by females with mild-to-moderate facial hyperpigmentation and fine lines due to photo-aging. The 12-week study concluded that the Even Up® Clinical Pigment Perfector® was shown to be effective and well tolerated for immediate and long-term improvement in the appearance of mild-to-moderate hyperpigmentation and fine lines associated with photo-damage when used over a 12-week period.

In a 12-week clinical trial, 94% of patients who used Even Up® twice a day in addition to their regular daily skincare and makeup regimen reported an improvement in the appearance of age spots and pigmentation, while 96% reported improvement in the appearance of skin evenness. In addition, 15% of participants noticed an improvement in their bare skin marked by a significant reduction in the appearance of pigmentation after 12 weeks.

“Even Up Clinical Pigment Perfector SPF 50 was the first 3-in-1 treatment product I worked on after joining Colorescience, and it is undoubtedly revolutionary. Being able to immediately conceal and brighten, plus offer long-term lightening results, and 100% mineral SPF 50 makes it truly one-of-a-kind,” noted Patricia Boland, VP of Research and Development.

About Colorescience®

For over 12 years Colorescience® has been blurring the lines between makeup and skincare to bring immediate beauty today while improving and protecting skin for tomorrow. Originally crafted for the most vulnerable post-procedure skin, Colorescience is trusted, recommended, and personally used by thousands of physicians. Using only substantiated ingredients in their purest form, and including them at therapeutic and dermatologist-approved levels for maximum efficacy and performance, Colorescience products have already improved millions of lives with 365-day protection from UV rays and environmental stressors. The brand’s uncompromising, health-forward approach to formulations provides confidence and reassurance to women of all ages, skin types and concerns. They understand the demands women face every day and realize the needs of today's consumer: ease, health, and beauty. Colorescience is changing the way women perceive beautiful skin; because beautiful isn’t just the prettiest—it’s the healthiest.

 

Colorescience® products are designed to easily fit into day-to-day life and are available through a network of licensed physicians, colorescience.com, and a collection of prestige retailers. For more information, visit www.colorescience.com.

For more information on Colorescience, please contact:
Behrman Communications, 212.986.7000
Amanda Youssef, ayoussef@behrmanpr.com
Emily Torrans, etorrans@behrmanpr.com


Download as a PDF